Home/Filings/4/0001209191-21-019772
4//SEC Filing

Brewis Neil 4

Accession 0001209191-21-019772

CIK 0001566373other

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 4:11 PM ET

Size

5.8 KB

Accession

0001209191-21-019772

Insider Transaction Report

Form 4
Period: 2021-03-09
Brewis Neil
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-03-09+22,56199,180 total
    Exercise: $7.24Exp: 2021-03-09Common Stock (22,561 underlying)
Footnotes (2)
  • [F1]These options were granted under the Issuer's 2015 Equity Incentive Plan.
  • [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 9, 2021, and thereafter in equal monthly installments over the remaining three years.

Issuer

F-star Therapeutics, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001831247

Filing Metadata

Form type
4
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:11 PM ET
Size
5.8 KB